Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Recruiting · NCT06950385 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm, polyp | Recruiting | Phase 3 | 2026-06-02 | NCT06950385 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biodexa Pharmaceuticals | 2 |
| Rapamycin Holdings Inc. | 2 |
29 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.